NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY) Stock Information | RedChip

NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY)


$0.7000
-0.0198 ( -2.10% ) 16.3K

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Market Data


Open


$0.7000

Previous close


$0.7198

Volume


16.3K

Market cap


$3.46M

Day range


$0.6850 - $0.7330

52 week range


$0.3611 - $11.4450

SEC Filings


Form Type Description Pages Date
8-k 8K-related 16 May 29, 2024
10-q Quarterly Reports 92 May 09, 2024
8-k 8K-related 37 Apr 22, 2024
8-k 8K-related 16 Apr 19, 2024
def Proxies and info statements 27 Apr 18, 2024
ars Annual reports 1 Apr 18, 2024
pre Proxies and info statements 28 Apr 08, 2024
10-k/a Quarterly Reports 18 Mar 29, 2024
10-k Annual reports 115 Mar 26, 2024
8-k 8K-related 14 Mar 26, 2024

Latest News